Vertex Pharmaceuticals (VRTX) Change in Receivables (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Change in Receivables of $140.2 million for Q2 2026, up 452.26% on a QoQ basis from -$39.8 million in Q1 2026, and up 661.96% year-over-year from $18.4 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Change in Receivables (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Change in Receivables for 18 years, with the latest figure at $140.2 million in Q2 2026.
- On a quarterly basis, Change in Receivables rose 661.96% year-over-year to $140.2 million in Q2 2026; TTM through Jun 2026 was $259.7 million, a 52.05% increase from a year earlier, with the FY2025 full-year figure at $347.3 million, up 249.75% from the prior year.
- Change in Receivables was $140.2 million for Q2 2026 at Vertex Pharmaceuticals, up from -$39.8 million in the prior quarter.
- The five-year high for Change in Receivables was $251.6 million in Q1 2024, with the low at -$135.1 million in Q2 2024.
- Average Change in Receivables over 5 years is $55.0 million, with a median of $55.8 million recorded in 2024.
- The largest YoY upside for Change in Receivables was 749.18% in 2024 against a maximum downside of 4758.62% in 2024.
- Over 5 years, Change in Receivables stood at -$10.2 million in 2022, then sank by 50.98% to -$15.4 million in 2023, then sank by 348.05% to -$69.0 million in 2024, then jumped by 244.06% to $99.4 million in 2025, then jumped by 41.05% to $140.2 million in 2026.
- The last three Change in Receivables figures came in at $140.2 million (Q2 2026), -$39.8 million (Q1 2026), and $99.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 1.18 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 140.20 Mn |
| Mar 31, 2026 | -39.80 Mn |
| Dec 31, 2025 | 99.40 Mn |
| Sep 30, 2025 | 59.90 Mn |
| Jun 30, 2025 | 18.40 Mn |
| Mar 31, 2025 | 169.60 Mn |
| Dec 31, 2024 | -69.00 Mn |
| Sep 30, 2024 | 51.80 Mn |
| Jun 30, 2024 | -135.10 Mn |
| Mar 31, 2024 | 251.60 Mn |
| Dec 31, 2023 | -15.40 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 90.50 Mn |
| Dec 31, 2022 | -10.20 Mn |
| Sep 30, 2022 | 119.50 Mn |
| Jun 30, 2022 | 84.10 Mn |
| Mar 31, 2022 | 165.20 Mn |
| Dec 31, 2021 | 43.50 Mn |
| Sep 30, 2021 | 185.30 Mn |
API Access
Vertex Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();